Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anthelminthic Agents01:15

Anthelminthic Agents

103
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
103
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

981
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
981
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

168
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
168
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

1.4K
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.4K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

1.8K
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.8K
Management of Insomnia01:19

Management of Insomnia

785
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
785

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal signals in dairy cattle slurry and fertilized field soil resistomes and bacterial communities.

Frontiers in microbiology·2026
Same author

A one health roadmap towards understanding and mitigating emerging Fungal Antimicrobial Resistance: fAMR.

npj antimicrobials and resistance·2024
Same author

Publisher Correction: Medical student wellbeing during COVID-19: a qualitative study of challenges, coping strategies, and sources of support.

BMC psychology·2024
Same author

Medical student wellbeing during COVID-19: a qualitative study of challenges, coping strategies, and sources of support.

BMC psychology·2024
Same author

National action plans on antimicrobial resistance in Latin America: an analysis via a governance framework.

Health policy and planning·2024
Same author

Biochar application to temperate grasslands: challenges and opportunities for delivering multiple ecosystem services.

Biochar·2023

Related Experiment Video

Updated: May 3, 2026

Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development
07:56

Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development

Published on: January 26, 2018

20.0K

Betamimetics for inhibiting preterm labour.

James P Neilson1, Helen M West, Therese Dowswell

  • 1Department of Women's and Children's Health, The University of Liverpool, First Floor, Liverpool Women's NHS Foundation Trust, Crown Street, Liverpool, UK, L8 7SS.

The Cochrane Database of Systematic Reviews
|February 7, 2014
PubMed
Summary

Betamimetics can delay preterm birth, allowing for interventions like corticosteroid treatment. However, these drugs have significant maternal and fetal side effects, and evidence does not support the use of specific betamimetics.

More Related Videos

Intrauterine Telemetry to Measure Mouse Contractile Pressure In Vivo
07:03

Intrauterine Telemetry to Measure Mouse Contractile Pressure In Vivo

Published on: April 6, 2015

9.3K
Identification Of Erythromyeloid Progenitors And Their Progeny In The Mouse Embryo By Flow Cytometry
08:59

Identification Of Erythromyeloid Progenitors And Their Progeny In The Mouse Embryo By Flow Cytometry

Published on: July 17, 2017

12.5K

Related Experiment Videos

Last Updated: May 3, 2026

Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development
07:56

Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development

Published on: January 26, 2018

20.0K
Intrauterine Telemetry to Measure Mouse Contractile Pressure In Vivo
07:03

Intrauterine Telemetry to Measure Mouse Contractile Pressure In Vivo

Published on: April 6, 2015

9.3K
Identification Of Erythromyeloid Progenitors And Their Progeny In The Mouse Embryo By Flow Cytometry
08:59

Identification Of Erythromyeloid Progenitors And Their Progeny In The Mouse Embryo By Flow Cytometry

Published on: July 17, 2017

12.5K

Area of Science:

  • Obstetrics and Gynecology
  • Pharmacology

Background:

  • Preterm birth is a leading cause of perinatal mortality and morbidity globally.
  • Betamimetics are tocolytic agents used to suppress uterine contractions, particularly in resource-limited settings.

Purpose of the Study:

  • To evaluate the efficacy and safety of betamimetics for women experiencing preterm labor.

Main Methods:

  • Systematic review of randomized controlled trials comparing betamimetics with placebo, no treatment, or other betamimetics.
  • Data extraction and risk of bias assessment were performed independently by two reviewers.

Main Results:

  • Betamimetics reduced births within 48 hours and seven days but did not significantly reduce preterm birth rates before 37 weeks' gestation.
  • No significant reduction in perinatal or neonatal mortality or respiratory distress syndrome was observed.
  • Common adverse effects included maternal chest pain, dyspnea, palpitations, tremor, and fetal tachycardia. Withdrawal from treatment due to adverse effects was also noted.

Conclusions:

  • Betamimetics can delay birth, potentially facilitating transfer to specialized care or completion of antenatal corticosteroid therapy.
  • The significant adverse effects profile necessitates careful consideration.
  • Current evidence is insufficient to recommend specific betamimetic agents over others.